Ticker
ORGOCompany Name
ORGANOGENESIS HOLDINGS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -46.37M | -10.8% | $ 429.53M |
3/31/2025 | $ -7M | -1.53% | $ 458.76M |
12/31/2024 | $ 4.18M | 0.87% | $ 482.04M |
9/30/2024 | $ 3.89M | 0.85% | $ 455.04M |
6/30/2024 | $ 8.52M | 1.9% | $ 448.39M |
3/31/2024 | $ 6.81M | 1.56% | $ 435.47M |
12/31/2023 | $ 6.55M | 1.51% | $ 433.14M |
9/30/2023 | $ -3.59M | -0.8% | $ 449M |
6/30/2023 | $ -19.3M | -4.22% | $ 457.33M |
3/31/2023 | $ -16.42M | -3.56% | $ 461.42M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Revenues
(=) FCF %
FCF % for ORGANOGENESIS HOLDINGS INC is calculated as follows: FCF [ $ -41.59M ] / Revenues [ $ 306.14M ]
(=) FCF % [ -13.59% ]
Minimum
Sep 30, 2020
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 3.18K |
---|---|
min | -58.23% |
max | 68.19% |
average | 7.86% |
median | 7.37% |
std | 19.48% |